Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Astellas Pharma Inc |
---|---|
Information provided by: | Astellas Pharma Inc |
ClinicalTrials.gov Identifier: | NCT00309101 |
The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.
Condition | Intervention | Phase |
---|---|---|
Myasthenia Gravis |
Drug: tacrolimus |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | FK506 Phase 3 Study: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients |
Estimated Enrollment: | 15 |
Study Start Date: | February 2006 |
Estimated Study Completion Date: | March 2009 |
Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Drug: tacrolimus
Oral
|
Ages Eligible for Study: | 16 Years to 64 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Clinical Development Administration, Astellas Pharma Inc. | clinicaltrials_info@jp.astellas.com |
Japan | |
Recruiting | |
Hokkaido region, Japan | |
Terminated | |
Tohoku region, Japan | |
Recruiting | |
Kanto region, Japan | |
Recruiting | |
Chubu region, Japan | |
Recruiting | |
Kyushu region, Japan | |
Terminated | |
Kansai region, Japan | |
Recruiting | |
Chugoku region, Japan | |
Completed | |
Shikoku region, Japan | |
Recruiting | |
Hokuriku region, Japan |
Study Chair: | Central Contact | Astellas Pharma Inc |
Responsible Party: | Astellas Pharma, Inc ( Director ) |
Study ID Numbers: | F506-CL-0602 |
Study First Received: | March 29, 2006 |
Last Updated: | July 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00309101 |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |
Tacrolimus Myasthenia Gravis |
Autoimmune Diseases Neuromuscular Diseases Myasthenia gravis |
Tacrolimus Myasthenia Gravis Autoimmune Diseases of the Nervous System |
Immunologic Factors Immune System Diseases Physiological Effects of Drugs Nervous System Diseases |
Neuromuscular Junction Diseases Immunosuppressive Agents Pharmacologic Actions |